Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1925 1
1934 1
1940 2
1942 1
1945 4
1946 10
1947 14
1948 23
1949 20
1950 45
1951 88
1952 95
1953 84
1954 84
1955 73
1956 101
1957 124
1958 160
1959 150
1960 126
1961 134
1962 180
1963 278
1964 411
1965 249
1966 235
1967 285
1968 298
1969 338
1970 334
1971 375
1972 373
1973 326
1974 348
1975 360
1976 395
1977 399
1978 557
1979 708
1980 947
1981 928
1982 972
1983 1132
1984 1174
1985 1233
1986 1210
1987 1147
1988 1248
1989 1371
1990 1270
1991 1319
1992 1229
1993 1250
1994 1203
1995 1286
1996 1312
1997 1326
1998 1298
1999 1304
2000 1306
2001 1434
2002 1362
2003 1459
2004 1733
2005 1886
2006 2031
2007 2226
2008 2263
2009 2456
2010 2734
2011 2884
2012 3226
2013 3514
2014 3907
2015 3918
2016 4298
2017 4311
2018 4530
2019 4553
2020 5845
2021 6417
2022 6049
2023 5608
2024 2026

Text availability

Article attribute

Article type

Publication date

Search Results

104,798 results

Results by year

Filters applied: . Clear all
Page 1
Pulmonary Hypertension: A Contemporary Review.
Johnson S, Sommer N, Cox-Flaherty K, Weissmann N, Ventetuolo CE, Maron BA. Johnson S, et al. Am J Respir Crit Care Med. 2023 Sep 1;208(5):528-548. doi: 10.1164/rccm.202302-0327SO. Am J Respir Crit Care Med. 2023. PMID: 37450768 Review.
Major advances in pulmonary arterial hypertension, pulmonary hypertension (PH) associated with lung disease, and chronic thromboembolic PH cast new light on the pathogenetic mechanisms, epidemiology, diagnostic approach, and therapeutic armament …
Major advances in pulmonary arterial hypertension, pulmonary hypertension (PH) associated with lung disea …
Metabolism in Pulmonary Hypertension.
Xu W, Janocha AJ, Erzurum SC. Xu W, et al. Annu Rev Physiol. 2021 Feb 10;83:551-576. doi: 10.1146/annurev-physiol-031620-123956. Annu Rev Physiol. 2021. PMID: 33566674 Free PMC article. Review.
Pulmonary arterial hypertension (PAH) is characterized by impaired regulation of pulmonary hemodynamics and vascular growth. Alterations of metabolism and bioenergetics are increasingly recognized as universal hallmarks of PAH, as metabolic abnormalities are
Pulmonary arterial hypertension (PAH) is characterized by impaired regulation of pulmonary hemodynamics and vascular gr
Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease.
Waxman A, Restrepo-Jaramillo R, Thenappan T, Ravichandran A, Engel P, Bajwa A, Allen R, Feldman J, Argula R, Smith P, Rollins K, Deng C, Peterson L, Bell H, Tapson V, Nathan SD. Waxman A, et al. N Engl J Med. 2021 Jan 28;384(4):325-334. doi: 10.1056/NEJMoa2008470. Epub 2021 Jan 13. N Engl J Med. 2021. PMID: 33440084 Clinical Trial.
BACKGROUND: No therapies are currently approved for the treatment of pulmonary hypertension in patients with interstitial lung disease. The safety and efficacy of inhaled treprostinil for patients with this condition are unclear. METHODS: We enrolled patients …
BACKGROUND: No therapies are currently approved for the treatment of pulmonary hypertension in patients with interstitial l
Pulmonary Hypertension and COVID-19.
Castiglione L, Droppa M. Castiglione L, et al. Hamostaseologie. 2022 Aug;42(4):230-238. doi: 10.1055/a-1661-0240. Epub 2021 Dec 21. Hamostaseologie. 2022. PMID: 34933375 Free article.
Coronavirus disease 2019 (COVID-19) is a primary respiratory infectious disease, which can result in pulmonary and cardiovascular complications. ...Clinical research on SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) suggests that the virus may determin …
Coronavirus disease 2019 (COVID-19) is a primary respiratory infectious disease, which can result in pulmonary and cardiovascu …
Sex and gender in pulmonary arterial hypertension.
Cheron C, McBride SA, Antigny F, Girerd B, Chouchana M, Chaumais MC, Jaïs X, Bertoletti L, Sitbon O, Weatherald J, Humbert M, Montani D. Cheron C, et al. Eur Respir Rev. 2021 Nov 8;30(162):200330. doi: 10.1183/16000617.0330-2020. Print 2021 Dec 31. Eur Respir Rev. 2021. PMID: 34750113 Free PMC article. Review.
Pulmonary arterial hypertension (PAH) is a rare disease characterised by pulmonary vascular remodelling and elevated pulmonary pressure, which eventually leads to right heart failure and death. ...
Pulmonary arterial hypertension (PAH) is a rare disease characterised by pulmonary vascular remodelling and elevated
[Schistosomiasis and pulmonary hypertension].
Şen N. Şen N. Tuberk Toraks. 2017 Sep;65(3):237-244. doi: 10.5578/tt.53798. Tuberk Toraks. 2017. PMID: 29135402 Free article. Review. Turkish.
The exact pathogenesis of schistosomiasis-associated pulmonary hypertension (S-PHT) remains unclear, although several mechanisms such as parazitic arterial embolisation, pulmonary arteriopathy, and portopulmonary hypertension have been suggested …
The exact pathogenesis of schistosomiasis-associated pulmonary hypertension (S-PHT) remains unclear, although several m …
Challenges and opportunities in treating inflammation associated with pulmonary hypertension.
Voelkel NF, Tamosiuniene R, Nicolls MR. Voelkel NF, et al. Expert Rev Cardiovasc Ther. 2016 Aug;14(8):939-51. doi: 10.1080/14779072.2016.1180976. Epub 2016 May 4. Expert Rev Cardiovasc Ther. 2016. PMID: 27096622 Free PMC article. Review.
INTRODUCTION: Inflammatory cells are present in the lungs from patients with many, if not all, forms of severe pulmonary hypertension. AREAS COVERED: Historically the first inflammatory cell identified in the pulmonary vascular lesions was the mast cell. ...A …
INTRODUCTION: Inflammatory cells are present in the lungs from patients with many, if not all, forms of severe pulmonary hypertens
Pulmonary hypertension inhaled therapies: An updated review.
El-Kersh K, Jalil BA. El-Kersh K, et al. Am J Med Sci. 2023 Jul;366(1):3-15. doi: 10.1016/j.amjms.2023.03.002. Epub 2023 Mar 13. Am J Med Sci. 2023. PMID: 36921672 Review.
Treatments of pulmonary hypertension (PH) continue to evolve with approval of new therapies. The currently FDA approved inhaled PH therapies include inhaled iloprost for group 1 pulmonary arterial hypertension (PAH), inhaled treprostinil solution and t …
Treatments of pulmonary hypertension (PH) continue to evolve with approval of new therapies. The currently FDA approved inhale …
Quantitative Proteomic and Phosphoproteomic Profiling of Lung Tissues from Pulmonary Arterial Hypertension Rat Model.
Luo A, Jia Y, Hao R, Yu Y, Zhou X, Gu C, Ren M, Tang H. Luo A, et al. Int J Mol Sci. 2023 Jun 1;24(11):9629. doi: 10.3390/ijms24119629. Int J Mol Sci. 2023. PMID: 37298580 Free PMC article.
Pulmonary arterial hypertension (PAH) is a rare but fatal disease characterized by elevated pulmonary vascular resistance and increased pressure in the distal pulmonary arteries. ...In this study, we performed tandem mass tags (TMT)-based relative quan
Pulmonary arterial hypertension (PAH) is a rare but fatal disease characterized by elevated pulmonary vascular resistan
Pathology and pathobiology of pulmonary hypertension.
Guignabert C, Dorfmuller P. Guignabert C, et al. Semin Respir Crit Care Med. 2013 Oct;34(5):551-9. doi: 10.1055/s-0033-1356496. Epub 2013 Sep 13. Semin Respir Crit Care Med. 2013. PMID: 24037624 Review.
Pulmonary hypertension is a devastating, life-threatening disorder with no curative options, characterized by elevated pulmonary vascular resistance and secondary right ventricular failure. Although the etiologies of pulmonary arterial hypertension
Pulmonary hypertension is a devastating, life-threatening disorder with no curative options, characterized by elevated pulm
104,798 results
You have reached the last available page of results. Please see the User Guide for more information.